Galectin-3 is shown to have dual activity, acting as an anti-tumor protein or aid in tumor progression, dependent on its localization in the nucleus or cytoplasm, respectively (Van Den Brule et al. 2000; Califice et al. 2004). This evidence concerns the gene LGALS3 and neoplasm.